SCHEMBL20142935

SCHEMBL20142935

O=C(N[C@H]1CC[C@H](C(=O)Nc2ccc(F)cc2Cl)CC1)c1cn2ccccc2n1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.56
▸ RAB9A P51151 6/20 0.56
▸ KDM4E B2RXH2 5/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ HPGD P15428 2/20 0.47
▸ TNKS O95271 1/20 0.45
▸ CNR1 P21554 1/20 0.43
▸ SSTR2 P30874 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PKM P14618 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20142939 1.00 NPC1 (0.56) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL20139053 0.84 NPC1 (0.47) NPC1RAB9ASMN1; SMN2HPGDCNR1
SCHEMBL20139050 0.84 NPC1 (0.47) NPC1RAB9ASMN1; SMN2HPGDCNR1
SCHEMBL20184974 0.82 SMN1; SMN2 (0.53) RAB9AKDM4EALDH1A1SMN1; SMN2HPGD
SCHEMBL18216201 0.82 SMN1; SMN2 (0.53) RAB9AKDM4EALDH1A1SMN1; SMN2HPGD
SCHEMBL20143023 0.82 CCNA2 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL20143024 0.82 CCNA2 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL18208565 0.80 EPHB3 (0.55) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL18208569 0.80 EPHB3 (0.55) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL20142934 0.80 HPGD (0.48) NPC1RAB9AALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO claimed
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO disclosed
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO disclosed
Send feedback